Obesity Clinical Trial
Official title:
STEP AND GO: A Study of Technology-based Exercise Promotion and Gaming Outcomes
NCT number | NCT01953224 |
Other study ID # | 13-0285 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2014 |
Est. completion date | November 2016 |
Verified date | April 2018 |
Source | The University of Texas Medical Branch, Galveston |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to test an intervention that uses a mobile game to encourage increased physical activity among adults.
Status | Completed |
Enrollment | 40 |
Est. completion date | November 2016 |
Est. primary completion date | November 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 69 Years |
Eligibility |
Inclusion Criteria: 1. Age between 18 and 69 years old 2. BMI is between 25 kg/m2 and 35 kg/m2 3. Able to read and understand English 4. Able to read words in standard applications on a mobile device 5" large 5. Able to walk for exercise 6. Able to find transportation to the study location 7. Willing to use a smartphone provided by the study to participate 8. Willing to listen to a potentially scary or sad story that includes violence 9. Willing to share basic information on walks with other participants via a social network Exclusion Criteria: 1. (If female) currently pregnant or nursing or plan to become pregnant in the next 6 months 2. Report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q, items 1 - 4). Reporting taking medicine for blood pressure on this questionnaire will require a doctor's note to participate. 3. Unable to walk for exercise (self-report) 4. Report current symptoms of alcohol or substance dependence 5. Plans to move away from the Galveston-Houston area in the next 4 months or to be out of town for more than 1 week during the study period 6. Unwillingness to report drugs taken for comorbidities such as hypertension or diabetes 7. Takes medications for diabetes or thyroid issues 8. Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months 9. Participant is active (60 minutes of moderate-vigorous intensity activity per week or more) 10. Another member of the household is a participant or staff member on this trial 11. Currently a participant in a physical activity or weight loss research trial 12. Recently (less than six months ago) completed a physical activity or weight loss research trial 13. Recently (less than six months ago) lost more than 5% of their body weight 14. Report a history of orthopedic complications that would prevent optimal participation in the physical activities prescribed (e.g., heel spurs, severe arthritis - may be eligible, but a doctor's note will be required) 15. Current smoker 16. Currently uses Zombies, Run! for exercise |
Country | Name | City | State |
---|---|---|---|
United States | The University of Texas Medical Branch | Galveston | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas Medical Branch, Galveston | American Heart Association |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of Participants Who Drop Out of the Study From Baseline to 12 Weeks | We will investigate the number of participants who drop out of the intervention group in comparison to the control group and to norms for similar studies | 12 weeks | |
Other | Acceptability | Acceptability will be self-reported using a variety of items taken from previous studies of physical activity interventions and usability | 12 weeks | |
Other | Frequency of App Use Over 12 Weeks | Based on objective measures taken from individual game accounts, we will determine the discrete number of uses of the game app | 12 weeks | |
Other | Number of Counseling Calls Completed From Baseline to 12 Weeks | Based on counselor logs, we will determine the number of counseling phone calls completed for each participant | 12 weeks | |
Other | Number of Participants With Adverse Events | We will inquire about potential adverse events during counseling calls and assessment visits. Discrete events will be summed, and the number of participants with events will be summed. | 12 weeks | |
Primary | Change in Physical Activity From Baseline to 12 Weeks | Minutes of physical activity measured over a 7 day period. Baseline values were carried forward for participants lost to followup. | Baseline to 12 weeks | |
Secondary | Change in Physical Fitness From Baseline to 12 Weeks | Maximal treadmill test to measure fitness (operationalized as the amount of oxygen used by the body during maximal effort). Baseline values were carried forward for participants lost to followup. | Baseline to 12 weeks | |
Secondary | Change in Body Fat Percentage From Baseline to 12 Weeks | We will use dual x-ray absorptiometry to measure body fat percentage. Baseline values were carried forward for participants lost to followup. | Baseline to 12 weeks | |
Secondary | Change in Blood Pressure From Baseline to 12 Weeks | Systolic and diastolic blood pressure will be measured using standard methods. Baseline values were carried forward for participants lost to followup. | Baseline to 12 weeks | |
Secondary | Change in Weight From Baseline to 12 Weeks | We will measure weight using a calibrated scale. Baseline values were carried forward for participants lost to followup. | Baseline to 12 weeks | |
Secondary | Change in Motivation From Baseline to 12 Weeks | We will measure intrinsic motivation using the intrinsic regulation subscale from the Behavioral Regulation in Exercise Questionnaire-2. This measure uses a scale from 0 (not true for me) to 4 (very true for me). Positive changes indicate increases in intrinsic motivation over time. Baseline values were carried forward for participants lost to followup. | Baseline to 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |